Skip to main content
. 2022 Dec 29;2022:8109977. doi: 10.1155/2022/8109977

Table 2.

Association of risk factors with HCV infection in hemodialysis patients.

Variable Anti-HCV (+)
(n = 94)
Anti-HCV (-)
(n = 244)
p value Odd ratio 95% CI
Gender
 Male 54 (57.0%) 152 (61.9%) 0.413 0.817 0.504-1.326
 Female 40 (43.0%) 92 (38.1%)
Age
 18-59 yr 65 (69.9%) 186 (74.3%) 0.182 1.431 0.844-2.425
  ≥60 yr 29 (30.1%) 58 (25.7%)
Duration of HD
  <5 yr 72 (76.6%) 157 (64.3%) 0.031 1.164 0.320-0.951
  ≥5 yr 22 (23.4%) 87 (35.7%)
Vascular access
 AV fistula 93 (98.9%) 168 (68.9%) <0.001 42.071 5.757-307.472
 Catheter double lumen 1 (1.1%) 76 (31.1%)
Dialyzer reuse
 Yes 82 (87.2%) 110 (45.1%) <0.001 8.324 4.319-16.044
 No 12 (12.8%) 134 (54.9%)
History of transfusion
 Yes 39 (41.5%) 112 (45.9%) 0.465 0.836 0.516-1.352
 No 55 (58.5%) 132 (54.1%)
History of surgery
 Yes 1 (1.1%) 0 (0%) 0.278a
 No 93 (98.9%) 244 (100%)
Diabetes mellitus
 Yes 16 (17.0%) 44 (18.0%) 0.827 1.019 0.497-1.749
 No 78 (83.0%) 200 (82.0%)
Hepatitis B infection
 Yes 1 (1.1%) 9 (3.4%) 0.281 1.256 0.128-2.941
 No 93 (98.9%) 235 (96.6%)
Type of HD unit
 Hospital 27 (28.7%) 183 (75.0%) <0.001 0.134 0.079-0.229
 Private 67 (71.2%) 61 (25.0%)

cell with value less than 5; Fisher exact test.